Exclusion of the Left Atrial Appendage (LAA) With the LAAx, Inc. TigerPaw System


Phase 2 Results N/A

Summary of Purpose

The dual primary safety and effectiveness outcomes for the use of The TigerPaw System include the rate of device related adverse and serious adverse events and the extent of complete exclusion of the LAA with minimal residual cavity.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 August 2009.

1 Aug 2009 19 Aug 2009 1 Dec 2009 1 Oct 2010 1 Aug 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment